6 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Agents for Treatment ... Clostridium difficile infection ... IDSA2017 #Adjunct #Antibiotics
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... can be community-acquired ... Tx Management (IDSA ... Ileus, Megacolon, Shock ... ciab549 #CDI #Cdiff
Causes of Antibiotic Failure - Differential Diagnosis Framework
Diagnosis:
 • Non-Infectious: Malignant, Autoimmune, Drug-related (NMS, serotonin syndrome,
Causes of Antibiotic ... Immunocompromise Treatment ... : • Antibiotic: ... • Secondary to Treatment ... (C diff) • Hospital-Acquired
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... of nonsurgical treatment ... 48–72 h if on treatment ... not otherwise required ... nonoperative #management #IDSA
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... : • The best treatment ... Microsporidiosis #IDSA ... #Prevention #Treatment ... #management #opportunistic